Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amantadine Addition to Paliperidone ER or Risperidone Consta Therapy for Prolactin Elevation

NCT00975611 is registered in ClinicalTrials.gov with David C. Henderson, MD as lead sponsor.

NCT NCT00975611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00975611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amantadine Addition to Paliperidone ER or Risperidone Consta Therapy for Prolactin Elevation
Lead sponsor
David C. Henderson, MD
Phase
Phase 4
Overall status
Terminated
Start date
October 31, 2009
Completion date
January 31, 2012
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia